Stevanato Group (NYSE:STVN) Stock Price Down 0.4% – Should You Sell?

Stevanato Group S.p.A. (NYSE:STVN)’s stock price traded down 0.4% during trading on Tuesday . The stock traded as low as €19.25 ($20.26) and last traded at €19.97 ($21.02). 28,083 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 506,196 shares. The stock had previously closed at €20.05 ($21.11).

Analyst Upgrades and Downgrades

A number of research firms recently commented on STVN. Citigroup decreased their price target on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Morgan Stanley reissued an “equal weight” rating and issued a $23.00 target price (down from $24.00) on shares of Stevanato Group in a research note on Tuesday.

Stevanato Group Price Performance

The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The stock’s 50-day moving average is €19.49 and its 200 day moving average is €19.60.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.16 EPS. As a group, sell-side analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently modified their holdings of STVN. Pier Capital LLC raised its stake in Stevanato Group by 44.5% in the 3rd quarter. Pier Capital LLC now owns 370,997 shares of the company’s stock valued at $7,420,000 after acquiring an additional 114,210 shares during the period. Kensington Investment Counsel LLC bought a new stake in shares of Stevanato Group during the 3rd quarter worth about $1,308,000. Wellington Management Group LLP lifted its position in Stevanato Group by 4.5% during the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after acquiring an additional 115,050 shares during the last quarter. Bamco Inc. NY grew its position in shares of Stevanato Group by 1.3% in the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock valued at $33,704,000 after purchasing an additional 21,469 shares during the last quarter. Finally, Fred Alger Management LLC increased its stake in shares of Stevanato Group by 24.2% during the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock worth $21,411,000 after purchasing an additional 208,830 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.